$Orphazyme A/S(ORPH)$Just a bit of warning as most traders here came from wsb or something:

 The FDA rejected their primary drug candidate. This is why the stock is down so much pre-market as it's a death sentence for small biotech firms in the short to medium term.

Company will only recover either with:

1. New data to reverse FDA decision

2. New drugs

3. Some weird retail push, but please know that everyone will sell this besides crazy wsb people I guess.

Point 1 and 2 can take a long time. So till then this can be close to dead.

Please do research, biotech companies live or die by trial results and FDA decisions, this is not just a dip.